Itraconazole in the treatment of acute and recurrent vulvovaginal candidosis: Comparison of a 1-day and a 3-day regimen

Mycoses

Volumn 48, Issue 3, 2005, Pages 165-171

  Spacek, Jiri ^a   Buchta, V ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Alopecia; Antifungal therapy; Itraconazole; Vulvovaginal candidosis

Indexed keywords

ITRACONAZOLE; TRIAZOLE DERIVATIVE;

ADULT; ALOPECIA AREATA; ANTIFUNGAL ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; FEMALE; FUNGUS CULTURE; HEADACHE; HUMAN; LIVER TOXICITY; LONG TERM CARE; MAJOR CLINICAL STUDY; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RASH; RECURRENT INFECTION; RELAPSE; SIDE EFFECT; STOMACH PAIN; SYMPTOMATOLOGY; TREATMENT OUTCOME; VAGINA CANDIDIASIS; VOMITING;

ADOLESCENT; ADULT; ALOPECIA AREATA; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RECURRENCE;

EID: 17844364902     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2005.01099.x     Document Type: Article

References (32)

1. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci 1988; 544: 547-57.
2. Odds FC (ed.). Chronic mucocutaneous candidosis. In: Candida and Candidosis. Baltimore, MD: University Park Press, 1988: 144-52.
3. Mendling W, Seebacher, C. Guideline vulvovaginal candidosis: Guideline of the German Dermatological Society, the German-Speaking Mycological Society and the Working Group for Infections and Infectimmunology of the German Society for Gynecology and Obstetrics. Mycoses 2003; 46: 365-9.
4. Ringdahl EN. Treatment of recurrent vulvovaginal candidiasis. Am Fam Physician 2000; 61: 3306-12.
5. Hurley R. Recurrent Candida infection. Clin Obstet Gynecol 1981; 8: 209-13.
6. Mårdh P-A, Rodrigues A, Gene M et al. Fact and myths on recurrent vulvovaginal candidosis - a review of epidemiology, pathogenesis, diagnosis and therapy. Int J STD AIDS 2002; 13: 522-39.
7. Mårdh P-A, Novikova N, Stukalova E. Colonisation of extragenital sites by Candida in women with recurrent vulvovaginal candidosis. BJOG 2003; 110: 934-7.
8. Fidel PL, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 1996; 9: 335-48.
9. Mendling W, Koldovsky U. Investigations by cell-mediated immunologic tests and therapeutic trials with thymopentin in vaginal mycoses. Inf Dis Obstet Gynecol 1996; 4: 225-31
10. Rees T, Phillips R. Multicenter comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis. Int J Gynecol Obstet 1992; 37(Suppl.): 33-38.
11. O'Connor MI, Sobel JD. Epidemiology of recurrent vulvovaginal candidiasis: identification and strain differentiation of Candida albicans. J Infect Dis 1986; 154: 358-63.
12. Mercure S, Poirier S, Lemay G et al. Application of biotyping and DNA typing of Candida albicans to the epidemiology of recurrent vulvovaginal candidiasis. J Infect Dis 1993; 168: 502-7.
13. Lynch ME, Sobel JD. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. J Med Vet Mycol 1994; 32: 267-74.
14. Lynch ME, Sobel JD, Fidel PL. Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis. J Med Vet Mycol 1996; 34: 337-9.
15. Fong IW, Bannatyne RM, Wong P. Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis. Genitourin Med 1993; 69: 44-46.
16. Buchta V, Špaček J. Microbiological findings in patients with recurrent vulvovaginal candidiasis at the University hospital Hradec Králové in 1995-2002. Čes Gynekol 2004; 69: 7-14.
17. Redondo-Lopez V, Lynch M, Schmitt C et al. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol 1990; 76: 651-5.
18. Sobel JD, Vazquez J, Lynch M et al. Vaginitis due to Saccharomyces cerevisiae - epidemiology, clinical aspects, and therapy. Clin Infect Dis 1993; 16: 93-99.
19. Spinillo A, Capuzzo E, Egbe TO et al. Torulopsis glabrata vaginitis. Obstet Gynecol 1995; 85: 993-8.
20. Young GL, Jewell D. Topical treatment for vaginal candidiasis in pregnancy. The Cochrane Library 2000; Issue 4.
21. Sobel JD. Treatment of vaginal Candida infections. Expert Opin Pharmacother 2002; 3: 1059-65.
22. Pappas PG, Kauffman CA, Perfect J et al. Alopecia associated with fluconazole therapy. Ann Intern Med 1995; 123: 354-7.
23. Kauffman CA, Pappas PG, McKinsey DS et al. Treatment of lymphocutaneous and visceral sporotrichosis with fluconazole. Clin Infect Dis 1996; 22: 46-50.
24. Stevens DA, Diaz M, Negroni R et al. Safety evaluation of chronic fluconazole therapy. Fluconazole Pan-American Study Group. Chemotherapy 1997; 43: 371-7.
25. Kantor J, Kessler LJ, Brooks DG, Cotsarelis G. Decreased serum ferritin is associated with alopecia in women. J Invest Dermatol 2003; 121: 985-8.
26. Yokoyama Y, Sato S, Saito Y. Alopecia related to low-dose oral contraceptive. Arch Gynecol Obstet 2002; 266: 46-47.
27. Tobin JM, Loo P, Granger SE. Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole. Genitourin Med 1992; 68: 36-38.
28. Stein GE, Mummaw N. Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis. Antimicrob Agents Chemother 1993; 37: 89-92.
29. Woolley PD, Higgins SP. Comparison of clotrimazole, fluconazole and itraconazole in vaginal candidiasis. Br J Clin Pract 1995; 49: 65-66.
30. Creatsas GC, Charalambidis VM, Zagotzidou EH et al. Chronic or recurrent vaginal candidosis: short-term treatment and prophylaxis with itraconazole. Clin Ther 1993; 15: 662-71.
31. Spinillo A, Colonna L, Piazzi G et al. Managing recurrent vulvovaginal candidiasis: intermittent prevention with itraconazole. J Reprod Med 1997; 42: 83-87.
32. Guaschino S, De Seta F, Sartore A et al. Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 2001; 184: 598-602.